Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONS… Ended

2024-512804-20-00 Metastatic Colorectal Cancer 5
A Phase 1/1b Open-Label Dose-Escalation and Dose-Optimization Study of Bcl-2 Inhibitor BGB 21447 in Patients With Mature B Cell Malignancies Ended

2025-521600-21-00 mature B-Cell malignancies 1
Induction of neo-antigen specific T cells by specialized cross-presenting dendritic cells in epithelial ovarian cancer patients treated with… Ended

2024-512353-24-01 Ovarian cancer 7
Randomized Phase II Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab in Locally Advanc… Ended

2024-515533-15-00 Locally advanced cervical cancer 4
A study to see how safe and effective the drug Luveltamab Tazevibulin (STRO-002) is in treating infants and children under 12 years old with… Ended

2023-506240-16-00 Acute Myeloid Leukemia (AML) 9
A Phase 1/2 Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors Ended

2022-503060-33-00 Advanced or Metastatic Solid Tumor Malignancies 4
The evaluation of the effectiveness, safety and tolerability of treatment, using a specialized prostate-specific membrane antigen (PSMA) lab… Ended

2023-504699-73-00 Adenoid cystic carcinoma 4
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metast… Ended

2022-503080-15-00 Cancer 1
A Phase 1 study to look at RP-6306 in combination with FOLFIRI as a treatment for Advanced Solid Tumours Ended

2024-511927-32-00 Advanced solid tumours 1
A trial to find out if vidutolimod together with cemiplimab is safe and if it works in adult participants with advanced cancer or metastatic… Ended

2023-507344-36-01 Advanced or Metastatic Cancer Merkel Cell Carcinoma (MC 4
A Phase 1a/1b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-5… Ended

2024-514704-13-00 Advanced or Metastatic Solid Tumors with KRAS Mutations 1
Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned… Ended

2025-520468-16-00 Cutaneous Melanoma, Relapsed/Refractory, Locally Advanc 4
An Open-Label, Multicenter, Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1604 in Adults with Advanced Melanoma Ended

2024-511949-19-00 Metastatic Melanoma 1
COMPRENDO - A PHASE II OPEN LABEL STUDY FOR THE COMPREHENSIVE ANALYSIS OF PREDICTORS OF THE TREATMENT WITH PEMBROLIZUMAB AND OLAPARIB IN PAT… Ended

2024-519350-37-00 patients with unresectable or metastatic HER2 negative 4
A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors Ended

2022-502622-40-00 Advanced Solid Tumors 1
DCC-3084 monotherapy in patients with solid tumors Ended

2024-517829-12-00 Solid tumors driven by the MAPK Pathway 7
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastro… Ended

2022-502087-21-00 Gastrointestinal Stromal Tumors (GIST) 7
Surgical or radiotherapeutic intervention concerning large singular stable to progressive metastases in patients with BRAFV600-mutated melan… Ended

2024-516073-74-00 Unresectable or metastatic melanoma with a BRAF V600 mu 6
A study to evaluate the safety and efficacy of mebendazole in combination with low-dose Ara-C in elderly patients with relapsed/refractory a… Ended

2024-518363-36-00 relapsed/refractory acute myeloid leukemia 4
A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Ref… Ended

2023-509472-42-00 Relapsed and/or Refractory Multiple Myeloma 5
A Study Testing a New Drug (ALT-803) With BCG to Treat Early-Stage Bladder Cancer Ended

2025-521223-78-00 Non-Muscle Invasive Bladder Cancer 4
A Phase I Study of INCB099280 in Combination With Ipilimumab in Participants With Selected Solid Tumors Ended

2023-503243-34-00 Solid tumor 3
SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study). Ended

2025-521235-37-00 small cell lung cancer, non-smallcell lung cancer, colo 1
LSTA1 Phase 2a basket trial in advanced solid tumors Ended

2023-503740-14-00 Head and neck cancer 4